You're reading the free version. Trader adds the live tape and alerts.
Start tracking
KNSA Exercise Disclosure
Ragosa Mark · SEC Form 4 · Filed Sep 3, 2026
Exercise
Calculated transaction value
$0
Ragosa Mark Chief Financial Officer
KNSA
Transaction date
Sep 1, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 2 days later
KNSA daily price context
Close on/before transaction
$79.28
Sep 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Share Unit on Class A Ordinary Share
- Quantity / price
- 1,750 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001835458-26-000012
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$349.15K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Award | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | Not reported |
| Kiniksa Pharmaceuticals International, Plc KNSA | Disposition | Sep 1, 2026 | $349.15K |
| Kiniksa Pharmaceuticals International, Plc KNSA | Award | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA Current | Exercise | Sep 1, 2026 | $0 |
| Kiniksa Pharmaceuticals International, Plc KNSA | Exercise | Sep 1, 2026 | $0 |